Epidemiological Analysis of Ambulant Patients in a COVID-19 Outpatient Clinic

April 26, 2022 updated by: Prof. Randerath, Wissenschaftliches Institut Bethanien e.V

There is insufficient knowledge about transmission routes and the effectiveness of general protective measures to prevent infection, such as the closure of schools or the wearing of mouthguards. This will be illustrated using the example of the COVID-19 outpatient clinic in Solingen and the positive COVID-19 tests registered there.

Another aspect we would like to address in this study is the number of COVID-19 tests performed against the background of political events or dramatic accumulations of COVID-19 cases in other parts of Germany or Europe. Do speeches by political leaders about the COVID-19 situation or a very strong regional spread of infection elsewhere have an impact on the frequency with which people react sensitively to suspicious symptoms and undergo testing for infection?

Study Overview

Status

Completed

Conditions

Detailed Description

The aim of this study is to analyse the frequency of positive COVID-19 tests and the infection chains in Solingen since February 2020:

  1. a prospective survey (telephone contact) of the positively tested patients is done to analyze the social environment and thus provide information about possible transmission routes. Is transmission mainly within the family through visits from relatives or rather through large extra-familial gatherings, such as in the case of the open huts and après-ski bars in Ischgl? Are there age- or gender-specific transmission routes (personal habits, travel)?
  2. analysis of the number of positive tests in connection with general measures to contain the infection (closure of schools, mouthguards obligation, etc.)
  3. characterization of positively tested patients based on anthropometric data and medical history.
  4. the effect of political events and developments in world affairs on the daily visitor frequency in the COVID-19 outpatient clinic will be retrospectively investigated. Is there an accumulation of tests after speeches by politicians or public figures (Angela Merkel, Armin Laschet, Queen Elizabeth II, etc.) or after dramatic infection numbers in other parts of Germany or Europe (Heinsberg, Ischgl, etc.)?

Study Type

Observational

Enrollment (Actual)

1316

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nordrhein-Westfalen
      • Solingen, Nordrhein-Westfalen, Germany, 42699
        • Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

all visitors of the outpatient clinic for COVID-19 since february 2020 in Solingen

Description

Inclusion Criteria:

  • positive COVID-19 test result

Exclusion Criteria:

  • negative COVID-19 test result
  • Any medical, psychological or other condition which restricts the ability to provide information or consent of the patient for voluntary participation in this examination

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
visitors of the outpatient clinic for COVID-19

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
possible risk factors
Time Frame: 0-4 weeks
medical history and medication of positive tested patients
0-4 weeks
frequency of positive test results after prescribed protective measures
Time Frame: about 8 months
frequency of positive test results after prescribed protective measures
about 8 months
frequency of positive test results within the family or other social groups
Time Frame: about 8 months
frequency of positive test results within the family or other social groups
about 8 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
number of COVID-19 tests in the outpatient clinic
Time Frame: about 8 months
number of COVID-19 tests in the outpatient clinic against the background of events in world affairs
about 8 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 2, 2020

Primary Completion (ACTUAL)

May 30, 2021

Study Completion (ACTUAL)

July 31, 2021

Study Registration Dates

First Submitted

July 2, 2020

First Submitted That Met QC Criteria

August 19, 2020

First Posted (ACTUAL)

August 20, 2020

Study Record Updates

Last Update Posted (ACTUAL)

April 27, 2022

Last Update Submitted That Met QC Criteria

April 26, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COVID-19

3
Subscribe